Health Care/Hospital
PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
DAEJEON, South Korea, May 10, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring non-clinical data of PMC-403 at the Association for Resea...
2021-05-10 20:00
1794
Bionomics BNC210 Expansion into Social Anxiety Disorder
* Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway * P...
2021-05-10 18:00
3668
Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...
2021-05-10 08:13
1781
Daewoong showed improved performance both sales and earnings in Q1
* OP. income exceeded 20 billion won due to successful export of Fexuprazan and sales recovery * Nabota(botulinum toxin) revenue soared after settlement, historical high performance in March * Turnaround in earnings just started and will continue to 2H SEOUL, South Korea, May 7, 2021 /PRNew...
2021-05-07 21:00
5165
Waterdrop Inc. Announces Pricing of Initial Public Offering
BEIJING, May 7, 2021 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, today announced the pricing of its initial public offering ("IPO") of 30,000,000 American depositary shar...
2021-05-07 18:00
5171
HanAll Biopharma Reports First Quarter 2021 Financial Results
* Q1'21 sales of KRW 27.8 billion increased 26% compared to Q1'20 * Q1'21 operating profit of KRW 5.4 billion increased 80% compared to Q1'20 * Q1'21 operating margin of 19%, up from 14% in Q1'20 * Better-than-expected sales and operating profit are largely due to an increase of R&D revenue...
2021-05-06 21:00
4713
China Jo-Jo Drugstores Hosts Reception for Provincial Government Officials
HANGZHOU, China, May 6, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or "the Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the C...
2021-05-06 20:30
3472
VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update
AUSTIN, Texas, May 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onWednesday May 12, at 8:00 a.m. Eastern time to discuss its financial and operating results for the first quarter of 2021, in addition to providing a bu...
2021-05-06 20:15
3834
VNTC Develops the World's First Hybrid Scoliosis Brace - Spinamic
* From a rigid to hybrid brace, Spinamic setting a new trend for scoliosis bracing * "A new treatment alternative for scoliosis patients" SEOUL, South Korea, May 5, 2021 /PRNewswire/ -- VNTC, a MedTech company, has developed Spinamic, the world's first vest-like wearable hybrid scoliosis brac...
2021-05-06 00:00
1775
Carmine Therapeutics appoints Don Haut as CEO
CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced thatDon Haut, PhD has been appointedas its Chief Executive Officer, and member of the Board of Directors. Founded and incubated by EVX Ventures, Carmine is developing ne...
2021-05-05 21:00
2324
Clarity receives US FDA clearance of IND Application for its next-generation PSMA theranostic products
SYDNEY, May 4, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has received a response from the U.S. Food and Drug Administration (FDA) on its Investigational New Drug (IND) appl...
2021-05-04 21:08
2084
Zepp Health Corp. to Report First Quarter 2021 Financial Results on May 13, 2021
BEIJING, May 4, 2021 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its first quarter of 2021 unaudited financial results before the marke...
2021-05-04 19:00
5592
HCmed Signs a Global Development Agreement with Global Biotechnology Leader CSL Behring
TAIPEI, May 3, 2021 /PRNewswire/ -- HCmed today announces the start of a strategic partnership with global biotherapeutics leader CSL Behring to collaboratively develop CSL Behring's plasma derived immunoglobulin administered via HCmed's new generation vibrating-mesh nebulizing device (CSL787). ...
2021-05-04 10:00
2043
Firmenich Opens Culinary & SmartProteins® Innovation Hub in Singapore
GENEVA, May 3, 2021 /PRNewswire/ -- Firmenich, the world's largest privately owned fragrance and taste company, today announces the launch of its Culinary and SmartProteins® Innovation Center in Tuas,Singapore. The new center will serve as a regional R&D hub forAsia and a global center of experti...
2021-05-03 23:23
2348
Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study
MINNEAPOLIS, May 4, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of the MODUS Study (ACTRN12620000412932), to treat patients with both type 2 diabetes and hypertension using a catheter-based, minimally invasive approach. The first procedures in this study were successfully com...
2021-05-03 21:00
1689
Jacobio Announces FDA Approves IND Application to Develop KRAS G12C Inhibitor
BEIJING and SHANGHAI and BOSTON, May 2, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) has announced the U.S. Food and Drug Administration (FDA) has approved company's Investigational New Drug (IND) application to develop a KRAS G12C inhibitor. IND application to the National Medical Pro...
2021-05-03 09:30
4494
Revotek Deploys Its Bioink Technology to Research Institutes
CHENGDU, China, April 29, 2021 /PRNewswire/ -- Recently, Revotek Co., Ltd. ("Revotek"), a vertically integrated biotech company specialized in 3D bioprinting, and West China Hospital ofSichuan University, a leading research hospital inChina, have reached an agreement, in which the latter shall i...
2021-04-29 21:30
1714
Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report
Highlights: * Michael J. Fox Foundation grants Alterity $US495K for Parkinson's disease research evaluation * Strengthening profile at investment, scientific and clinical conferences * Dr David Stamler appointed Chief Executive Officer * Cash balance as at 31 March 2021 of A$32.8M MELBOURN...
2021-04-29 20:30
6185
I-Mab Announces Upcoming Participation at May Conferences
SHANGHAI and GAITHERSBURG, Md., April 29, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in May. ...
2021-04-29 20:00
3593
I-Mab Filed 2020 Annual Report on Form 20-F
SHANGHAI and GAITHERSBURG, Md., April 28, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company has filed its annual report on Form 20...
2021-04-28 20:00
1983
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025
[Picked up by 288 media titles]
2025-12-08 11:00
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 286 media titles]
2025-12-10 16:00